Paras Biopharmaceuticals Finland is a biopharmaceutical technology development company specializing in biologics and biosimilar technologies. The company has developed therapeutic products to treat several ailments, including osteoporosis, rheumatoid arthritis, and metabolic disorders. Paras Biopharmaceuticals has also developed proprietary technologies for the production and expression of peptides and proteins.